NCT06631105 Capability Assessment for Diet and Activity (CADA) Model for Diabetes
| NCT ID | NCT06631105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-01-10 |
| Primary Completion | 2026-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-01-10 with a primary completion date of 2026-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the capabilities related to diet, physical activity, screening, and knowledge among diabetic adults with or without a history of hospital admissions in Central Florida. The hypothesis is that enhancing these capabilities, based on the Capability Approach framework, can significantly reduce hospital readmissions and improve diabetes management outcomes.
Eligibility Criteria
Inclusion Criteria: * Adults over the age of 18. * Persons diagnosed with diabetes * Have an email account with access to a reliable internet connection or smartphone Exclusion Criteria: * Minors , ages under 18 * Adults not diagnosed with diabetes * Adults who are unable to provide consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06631105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06631105 currently recruiting?
Yes, NCT06631105 is actively recruiting participants. Contact the research team at Amoy.Fraser@ucf.edu for enrollment information.
Where is the NCT06631105 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06631105 clinical trial?
NCT06631105 is sponsored by University of Central Florida. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.